Lanzatech co-founder: we are missing out on the synthetic biology revolution

Lanzatech co-founder: we are missing out on the synthetic biology revolution
Dr Sean Simpson. (Image: Getty)
Peter Griffin
The third New Zealand-founded company in as many years is set to list on the Nasdaq.LanzaTech’s merger with “blank cheque” Nasdaq-listed company AMCI Acquisition Corp II sees it follow in the footsteps of Rocket Lab and footwear maker All Birds in taking the special purpose acquisition company (SPAC) route to become a publicly traded company.The deal, which values the merged company at around US$1.8 billion (NZ$2.8b), was cleared by shareholders on Tuesday. It confirms the Illinois-based LanzaTech’s status as our mo...

More Opinion

The art of continuous investment improvement
Opinion

Simon Robertson: The art of continuous investment improvement

The point is to build yourself an investment framework; here's how. 

Simon Robertson 04 May 2024
Fish rots from the head
Opinion

Julia Jones: Fish rots from the head

Remember, doing nothing is as risky as taking action.

Julia Jones 03 May 2024
Where Callaghan Innovation is heading with its ‘strategic reset’
Opinion

Peter Griffin: Where Callaghan Innovation is heading with its ‘strategic reset’

Company's future rests on big decisions the government needs to make.

Peter Griffin 02 May 2024
Containing multitudes: diversity inside the KiwiSaver envelope
Opinion

David Chaplin: Containing multitudes: diversity inside the KiwiSaver envelope

Multi-scheme membership might just be a complex solution to a non-existent problem.

David Chaplin 01 May 2024